Roadmap


Research


We are currently partnering with multiple institutions to run statistical analyses on existing datasets that contain aggregate data on psychedelic use.

We plan to fund and conduct a randomized controlled clinical trial:

  • Please see link for proposed clinical trial – Click here
  • We will need to raise approximately $500,000 USD to carry out this clinical trial
  • After we raise all necessary funds, we will begin recruitment for the clinical trial

Advocacy


We support rescheduling psychedelic drugs out of Schedule 1 so as to allow for more research on psychedelics.

Treatment


In addition to carrying out clinical research and advocating for rescheduling, our goal is to provide evidence-based, trauma-informed psychedelic-assisted therapy, regardless of socioeconomic status.

We will begin offering therapy after MDMA and/or psilocybin become FDA-approved.

Clinical Trials

Read about our past, current, and future clinical trials.